High temporal resolution DCE MRI of breast cancer treated with neo-adjuvant chemotherapy and analyzed with both distributed parameter and modified Tofts tracer kinetics models
Dennis Lai-Hong Cheong1, Bo Zhang1, Bingwen Zheng1, Limiao Jiang1, Eugene Wai Mun Ong2, Soo Chin Lee3,4, and Thian C Ng1

1Clinical Imaging Research Centre, A*STAR-NUS, Singapore, Singapore, 2Department of Diagnostic Imaging, National University Hospital in Singapore, Singapore, Singapore, 3Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore, 4Cancer Science Institute of Singapore, Singapore, Singapore

Synopsis

Higher resolution DCE-MRI is readily attainable and should allow for more realistic distributed parameter tracer kinetics models to be used. However, simpler, faster and lesser parameters compartmental models such as the modified Tofts model are still preferred by many researchers. We present here how we have implemented a distributed parameter model to analyze 2.4sec/frame DCE MRI data in a clinical trial of neo-adjuvant chemotherapy with or without short-course anti-angiogenic therapy in breast cancer patients. The results from modified Tofts and the distributed parameter model differ. More realistic distributed parameter models might be better in analyzing high temporal resolution DCE-MRI data.

Introduction

Dynamic Contrast-Enhanced (DCE) MRI has been widely used to assess breast tumor microvasculature. Temporal resolution has reduced from above a minute, which are multiple high spatial resolution post-contrast acquisitions, to about 4s, which is considered very fast. Analysis methods range from qualitative visual inspection of signal intensity time curves, to semi-quantitative parameters such as time to peak and uptake slope of intensity or tracer concentration time curves (C(t)), and to quantitative tracer kinetics (TK) analysis. Compartmental models are more commonly used for quantitative analysis while more realistic distributed parameter (DP) models1 are less commonly used. Here, we report on high temporal resolution DCE-MRI analyzed with both types of TK models in a clinical trial that assess early chemotherapy response with or without anti-angiogenesis pre-treatment, in breast cancer.

Methods

Sixty-four newly diagnosed breast cancer patients in an on-going clinical trial who were scheduled to receive neo-adjuvant chemotherapy (doxorubicin/cyclophosphamide (AC)), were randomly assigned to receive an additional low-dose (oral Sunitinib (Su) at 12.5mg/d) short-duration (7 days) anti-angiogenesis pre-treatment (ARM-B) or not (ARM-A)2. DCE-MRI data were acquired at these time points: before anti-angiogenic pre-treatment using Sunitinib, before and after first cycle of chemotherapy.

MRI scans were performed on a whole-body 3T MRI (Magnetom Trio; Siemens, Germany) with a seven-channel breast receiver coil and an additional surface coil placed on their back for better imaging of the descending aorta. Axial DCE-MRI were scanned in the prone position with a spoiled 3D FLASH acquisition (TR=4ms, flip angle (FA)=15°, matrix=128×128, 16x4mm slices to cover whole tumor, temporal resolution=2.4s/f). T1 maps were acquired with variable FA (FAs=5°/13°/20°, TR=20ms) for computation of tracer concentrations. B1 maps were acquired using the system RF sequence for B1 correction.

Both the modified Tofts (mT) and 2-comparment DP models1 were used to analyze the DCE data. AIF is measured from the fourth inferior slice at the descending aorta to reduce in-flow effects. A physiological based AIF model3 was fitted to the AIF data and later used in the fitting of the tissue C(t). This allows AIF arrival time to be adjusted freely while fixing the TK impulse response function (IRF) to always start at time 0 to overcome the issue with discontinuity at the bolus arrival time. Discontinuity issue at the mean vascular transit time (tp in Figure 1 right) the DP model is handled by up-sampling of AIF and IRF by 10 times, before applying the correction method by Koh et al.4 Using an analytical AIF form further smooths the search surface during curve fitting. All processing were performed on MatLab, where the expansion series form of the DP model5 was implemented for faster computation.

Results

Figure 1 shows typical AIF and tissue C(t). The high temporal resolution clearly captured the first bolus and a second smaller peak in the AIF. Our AIF model managed to fit the AIF data appropriately. We notice the scaled AIF in the mT model did not match the initial part of many tissue C(t) (Figure 1 centre). The Ktrans and permeability surface-area product (PS) maps (Figure 2) were similar but differed in values. Table 1 shows the results from 48 patients who had completed all scans. All parameters did not show any significant difference in ARM-A. In ARM-B, fractional plasma volume (vp) and fractional extravascular extracellular volume (ve) in the mT model showed more changes than vp and ve in the DP model (circles in Table 1). However, DP permeability measures (PS, Ktrans (see below) and first pass extraction ratio (E)) showed significant changes at post-AC while mT Ktrans did not. Perfusion (F) measured by DP showed no significant changes between all scans. The Ktrans in DP model is defined as E×F.

Discussion

We have performed high temporal resolution DCE MRI of breast cancer and analyzed the data with more realistic DP and the commonly used mT models. The initial AIF features captured in our data illustrated a misfit issue (Figure 1 centre) in the mT model. Although permeability measures from both models showed similar trend, mT Ktrans and ve were much higher than those of DP model. Since mT Ktrans also contains perfusion contributions, and there was no significant changes in the perfusion as measured by DP F, we suspect this could have muddled the values in mT Ktrans to not reflecting significant changes in permeability while all three permeability measures of DP model have.

Conclusion

The difference between mT and DP models is noticed in analyzing high temporal resolution. More realistic distributed parameter models might be better in analyzing high temporal resolution DCE MRI data.

Acknowledgements

This study is supported by grants NMRC/CSI/0015/2009 (SCL) and R-180-000-016-733 (TCN).

References

1. Koh TS et al. Fundamentals of Tracer Kinetics for Dynamic Contrast-Enhanced MRI. JMRI 2011 34:1262-76.

2. Ng TC et al. Dynamic-Contrast-Enhanced MRI and Dynamic Tensor Imaging (DTI) for the Early Detection of Anti-angiogenic Effect and Vessel “Normalization” in Human Breast Cancer Treated with Neoadjuvant Chemotherapy. Proc. ISMRM 2015:0605.

3. Cheong DLH and Ng TC. Proc. ISMRM. A physiological model for injected contrast agent concentration incorporating recirculation, extravasation and excretion 2013:3063

4. Koh TS, Cheong DLH and Hou Z. MRM. Issues of Discontinuity in the Impulse Residue Function for Deconvolution Analysis of Dynamic Contrast-Enhanced MRI Data. MRM 2011 66:886-892.

5. Koh TS. On the a Priori Identifiability of the Two-Compartment Distributed Parameter Model From Residual Tracer Data Acquired by Dynamic Contrast-Enhanced Imaging. IEEE Trans. Biomed. Eng. 2008 55:340-344.

Figures

Figure 1. AIF (left) fitted with a physiological based AIF model. A tracer concentration time curve of a tumor pixel (center) fitted by the mT (black) and DP (blue) models. The model IRFs are shown on the right, where the mT IRF includes a Dirac delta function at time=0 of area=vp.

Figure 2. Ktrans maps from mT (left) and DP (center) models, and DP PS map (right), overlaid on post-contrast T1w image.

Table 1. Results from DCE MRI analyzed by mT and DP models. Mean ± standard error are shown. One-tail paired t-tests were performed.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0652